Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Neostem Company Profile (NYSE:NBS)

Consensus Ratings for Neostem (NYSE:NBS) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.50 (184.26% upside)

Analysts' Ratings History for Neostem (NYSE:NBS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/2/2014AegisBoost Price TargetBuy$21.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
9/12/2013MLV & Co.Initiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
6/24/2013AegisInitiated CoverageBuy$2.50ViewTweet This Rating  Share This Rating on StockTwits
3/18/2013JMP SecuritiesLower Price TargetMarket Outperform$3.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2013Brinson PatrickInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
3/7/2013Brinson PatrickInitiated CoverageOutperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
10/9/2012Chardan CapitalInitiated CoverageBuy$2.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2012WBB SecuritiesUpgradeBuy -> Strong-Buy$2.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/25/2012 forward)